Piper Sandler Maintains Overweight on Biomea Fusion, Raises Price Target to $19
Portfolio Pulse from Benzinga Newsdesk
Piper Sandler analyst Joseph Catanzaro has maintained an Overweight rating on Biomea Fusion (NASDAQ:BMEA) and raised the price target from $10 to $19.
October 31, 2024 | 6:24 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Piper Sandler has increased its price target for Biomea Fusion from $10 to $19, maintaining an Overweight rating. This suggests a positive outlook for the company's stock.
The increase in price target from $10 to $19 by Piper Sandler indicates a strong positive sentiment towards Biomea Fusion's future performance. Maintaining an Overweight rating further supports the expectation of stock price appreciation.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100